BSI Joins the Avicenna Alliance to Advance Trust in In Silico Medicine

The Avicenna Alliance is delighted to welcome the British Standards Institution (BSI) – Standard Organization and Leading Notify Body – as its newest Partner, further strengthening our collective commitment to advancing the safe, effective and trusted adoption of in silico methods in healthcare.

Within the healthcare sector, BSI Regulatory Services supports organizations in navigating complex regulatory landscapes across medical devices, in vitro diagnostics, artificial intelligence and digital health. By combining technical expertise with global regulatory insight, BSI helps innovators bring safe, compliant products and services to market while meeting the highest standards of safety, quality and performance.

"We – as the leading Notified Body in Medical Devices – are joining the Alliance to help advance global confidence in in silico methods, based on our long-established expertise and thought leadership in medical devices, in vitro diagnostics, and artificial intelligence. Our objective is to support robust, evidence-based innovation that accelerates safer, more effective healthcare while upholding the highest standards of trust and regulatory integrity", said Dr. Michael Weissig, Global Managing Director Medical Devices, BSI.

Welcoming BSI to the Alliance, Thierry Marchal, President and Secretary General of the Avicenna Alliance, added: "We are pleased to welcome BSI to the Avicenna Alliance. As the adoption of computational modelling, simulation and AI continues to grow across healthcare, trusted regulatory expertise is essential to translating innovation into clinical practice. BSI's global leadership, technical excellence and long-standing commitment to quality and safety will be a tremendous asset to our community as we work together to strengthen confidence in in silico medicine and accelerate its responsible adoption worldwide."

The Avicenna Alliance looks forward to collaborating with BSI and its experts across our working groups and initiatives to foster international collaboration, support regulatory science, and promote the broader adoption of evidence-based in silico approaches that improve patient outcomes.

Welcome to the Avicenna Alliance, BSI!